SlideShare a Scribd company logo
DR. BHARAT BHUSHAN
(DM-NEUROLOGY)
ASSOCIATE PROFESSOR
GOVERNMENT MEDICAL COLLEGE,KOTA
PHENOMENOLOGY
• Alcoholic = Person (T1>25yr M/F, T2<25yr male only)
• Alcoholism =Illness (abuse /dependence)
• Physical Dependence :The development of withdrawal
symptoms once a drug is stopped.
• Binge Drinking: A “binge” is a pattern of drinking alcohol
that brings BAC to 0.08 gm% or above. >5 drinks (male)
or >4 drinks (female) in about 2 hours.
• Craving:- The desire to experience the effects of a
previously experienced psycho-active substance.
• Tolerance:- represents a CNS pharmacodynamic adaptive
response which improves neurologic function at a given
blood alcohol level.
METABOLISM
• Role of alcoholism in the development of cognitive and
functional decline has been known since the time of
Hippocrates
• Two-carbon molecule that rapidly diffuses into virtually every
biologic compartment in the body upon ingestion.
• Women have a lower alcohol dehydrogenase blood content
than Men.
Rate of oxidation is
constant(15mg/dl/hr) does
not depend on plasma level.
NEUROTRANSMITTER
ALCOHOL AND THE BRAIN TRANSCRIPTOME
• Chronic exposure acts by many multiple myelin-
related genes /ligand-gated ion channels /
neuromodulatory molecules /Neuroinflammatory
signaling genes are in both humans and animal
models (Blednov et al., 2011, 2012).
• Genetic predisposition - 50% of the vulnerability
for developing alcohol dependence (Goodwin et
al., 1974; Prescott and Kendler, 1999).
• Polymorphisms in isoforms of ADH and ALD genes,
which influence alcohol metabolism and the risk
for alcoholism (Park et al., 2013).
ALCOHOL AND THE BRAIN TRANSCRIPTOME
SPECTRUM
Acute
Acute alcoholic intoxication
Alcoholic blackout
Alcohol withdrawal syndromes
• Minor = Tremulousness, 6-
24 hr
• Major = Hallucinosis 10-72
hours
• Withdrawal seizures=Rum fit
, within 6-48 hrs
• Delirium tremens (DTs):-3-10
days
Chronic
Nutritional deficiencies:
Wernicke-Korsakoff syndrome.
Alcoholic polyneuropathy
Pellagra
Uncertain etiology
• Alcoholic cerebellar
degeneration.
• Central pontine myelinolysis.
• Marchiafava-Bignami disease
• Alcoholic myopathy.
• Alcoholic neuropathy
ACUTE EFFECTS- INTOXICATION
• Intoxication occurs –d/t readily crosses the BBB
• Facilitation of GABA and Inhibition of Glutmate
• Clinical intoxication is related to the rate of blood
ethanol increase and the individual’s ethanol
tolerance (d/t Zero order kinetics).
INTOXICATION
• EEG :- beta (fast) activity ----> slowing.
• Reduces sleep onset latency , sleep efficiency ,
duration of REM sleep and with diminished
perceived sleep quality.
Rx:-Supportive.
• Low dose BZD: Lorazepam PO/IV 1-2mg
• Alternative: Antipsychotic Haloperidol or
Olanzenpine.
• Parenteral thiamine should also used
ALCOHOL BLACKOUTS
• Alcohol blackouts occur in the absence of any
loss of consciousness or seizure activity and
represent a type of anterograde amnesia.
• Fragmentary or en bloc alcohol blackouts .
• Perhaps by interfering with septohippocampal
regulation of hippocampal neuronal circuitry
(Givens et al., 2000).
ALCOHOL WITHDRAWAL SYNDROME
Withdrawal
A physiological state, d/t cessation/reduction in
amount of drug ,Generally opposite of drug’s
normal effects.
Spectrum AWS
• Minor withdrawal= Tremulousness, 6-24 hrs
• Major withdrawal= Hallucinosis 10-72 hours
• Withdrawal seizures=Rum fit ,within 6-48 hrs
• Delirium tremens (DTs):-3-10 days
ALCOHOLIC HALLUCINOSIS
Alcoholic hallucinosis:
– Occurs in about 2% of patients
– Characterized by presence of hallucinations
[usually auditory] during partial or complete
abstinence, following regular alcohol intake.
Treatment:
– Lorazepam oral 3-10 mg every 4-6 hr
– Correction of electrolyte disorders: hypokalemia
and hypomagnesemia, hyperthermia,
ALCOHOLIC SEIZURE (RUM FITS)
– GTCS & multiple seizures occur in about 10% of
alcohol dependence patients, usually 12 to 48 hrs
after abstinence.
– Sometimes status epileptics can be precipitated
(less than 3%)
– Unless an underlying neuropathology exists,
seizures are rarely focal.
– Seizures sometimes occur during heavy drinking or
after more than a week without alcohol
– Arrhythmias and sudden cardiac death can occur.
– EEG are mildly abnormal and usually revert to
normal within few days
EFNS- RECOMMENDATION(2011)
Treatment: BDZ: Diazepam: IV 0.5 mg/kg at 2.5 mg/ min
No WS/Mild to Moderate symptoms no routine seizure prevention(Level B ).
Severe alcohol withdrawal symptoms, regardless of seizure occurrence, should
be treated pharmacologically (Level C recommendation).
Status epilepticus: i.v. lorazepam is safe and efficacious. When unavailable, i.v.
diazepam is a good alternative (Level A recommendation).
Primary Preventions
BZD for primary prevention of seizures in a person with alcohol withdrawal,
as well as for treatment of the alcohol withdrawal syndrome. Other drugs for
detoxification should only be considered as add -on (Level A).
Secondary prevention
BZD should be used for the secondary prevention of AWS (Level A).
Phenytoin is not recommended for prevention of AWS recurrence (Level A
recommendation).
The efficacy of other antiepileptics for secondary prevention of AWS is
undocumented.
DELIRIUM TREMENS
Occurs within 3 to 4 days
Features of:-
- Clouding of consciousness with disorientation
in time and place with tremulousness of body
- Poor attention span and distractibility
- Visual hallucinations and illusions
- Marked autonomic disturbances
- Insomnia
- Dehydration with electrolyte imbalance
Treatment: 50-100 mg Chlordiazepoxide every 4
hrs orally or Lorazepam IV 0.1 mg/kg at 2 mg/min.
 Prevention: 25-50 mg of Chlordiazepoxide every 2-4 hrs until out of
danger.
 High calorie, high carbohydrate diet given with Thiamine
suppliment.
CHRONIC COMPLICATIONS
Alcoholic Pellagra
• Disease of cerebral function attributed to
deficiency of nicotinic acid or tryptophan (Serdaru et al
1988; Victor 1994).
• Rare now because of widespread practice of
niacin supplementation of cereals and bread
• Initial symptoms are mood changes and
neurasthenia.May progress to lethargy and
confusion, variably accompanied by spastic
paresis, paratonia, or myoclonus.
Wernicke-Korsakoff Syndrome
German neurologist and
psychiatrist, born May 15, 1848,
Tarnowskie Gory, Poland; died
June 15, 1905,
Russian neuropsychiatrist,
born January 22, 1853,
Gus estate, Vladimirsk; died
May 1, Moscow, 1900.
Karl Wernicke(1848-1905)
WERNICKE ENCEPHALOPATHY
• WE is an acute, potentially reversible,
neuropsychiatric disorder caused by thiamine
deficiency (Donnino et al., 2007; Isenberg-Grzeda et al., 2012).
• The incidence can be as high as 12.5%
• The altered cognition of WE can progress to
KS, a chronic and usually permanent.(Toth et al., 2002).
• Approximately 80% of patients with acute WE
will develop KS (Donnino et al., 2007).
• Mechanism:- Chronic alcoholism– Malnutrition –
reduced thiamine uptake and utilization
PHYSICAL EXAMINATION
• The diagnosis of Wernicke syndrome is often suspected
based on clinical grounds.
• Theclassicaltriadofsymptoms–only1/3rd ofcases
• Ocularabnormalities–nystagmus,bilaterallateral
rectuspalsies,conjugategazepalsies,sluggishpupils,
ptosis,andanisocoria
• Encephalopathy– globalconfusionalstate,disinterest,
inattentiveness,or agitation;Comaisrare.
• Gaitataxia– cerebellardamage,andvestibularparesis
• Peripheralneuropathy– foot drop,anddecreased
proprioception
20
Figure 1. [A and B] FLAIR images depicting hyperintensities in the periaqueductal
region [A] and medial thalamus [B]. Pre- [C] and Post- [D] contrast T1-weighted images
showing contrast enhancement of the mammillary bodies.
Wernicke-Korsakoff Syndrome
Differential Diagnosis
• Psychosis
• Normal pressure hydrocephalus
• Cerebrovascularaccident
• Chronic hypoxia
• Closed-head injury
• Hepatic encephalopathy
• Postictal state
WORK-UP
• Erythrocyte transketolase activity assay,
Thiamine assay – very specific tests – not
widely available – reserved for diagnostic
dilemmas
• EEG and CSF analysis may exclude other
explanatory or concomitant conditions.
TREATMENT
• Emergencydepartmentcare–Parenteralthiamine–Requirementin
chronicalcoholicsmaybeas highas500mgsingledoseormultipledaily
doses.
• NeverstartonDextrose
• Treatment with thiamine repletion, currently recommended at 1 gram of
IV thiamine per 24 hours for alcoholics with suspected Wernicke
encephalopathy , should not be delayed.
• Death occurs in nearly 20 % of patients with delayed treatment.
• Parenteralmagnesiumsulfateasthiaminetherapyineffectivein
presenceofhypomagnesemia.
• In-Patientcare–Watchforcomplications–Korsakoffpsychosis–Alcohol
withdrawal–Congestiveheartfailure–Lacticacidosis
• Out-PatientCare–Thiamine100mgPOdaily,startalcoholcessation
program,Adviseonimportanceofbalanceddiet.
24
KORSAKOFF SYNDROME:-
• Another CNS syndrome resulting from thiamine
deficiency in alcoholics.
• It manifests with Psychosis, memory loss and confabulation,
abulia.
• Korsakoff syndrome is distinguished from acute
Wernicke syndrome by prominent anterograde and
retrograde amnesia without substantially impaired
alertness and attention or extraocular movement
disturbance.
• 85% of the survivors of the acute phase of Wernicke
encephalopathy who remain untreated go on to develop
Wernicke-Korsakoffsyndrome.
• 20% eventuallyrecovercompletelyduring long-termF/U care.
KORSAKOFF SYNDROME
• Epidemiologicallly cases of undiagnosed Wernicke
syndrome can progress to Korsakoff syndrome.
• Patients may have a significant degree of
vacuous spontaneous speech and abulia that
may be mistaken for depressive symptoms when
inadequately explored.
• Thalamus (particularly the anterior thalamic
nucleus) and hypothalamus (medial mammillary
nucleus) are injured , but other cortical and
subcortical areas modulate this process.
PROGNOSIS OF WKS
• 10-20% mortality rate (in acute stages)
• In general, full recovery of ocular function occurs. Fine
horizontal nystagmus can persist in - 60% of cases.
• Approximately 40% of patients have complete recovery
from ataxia.
• Of patients surviving WE 80% have Korsakoff psychosis.
• KS 25% do not recover, require long-term admission.
• Only about 20% eventually recover completely during
long-term follow-up care.
• Only 20% of patients recover completely from amnestic
deficit.
• Despite appropriate treatment ,measureable memory
deficiency may persist for upto 2 years in patients with
Wernicke encephalopathy.
ALCOHOL RELATED DEMENTIA
• Represent approximately 10% of all cases of dementia
(Gupta and Warner, 2008).
• With advancing age , patients who are chronic
alcoholics may develop cognitive impairment or
dementia without demonstrable micronutrient
deficiency.
• Synergistic in the expression of other cognitive
disorders of aging.
• Clinically, patients with alcohol related dementia
typically present at an earlier age than other acquired
or late-onset forms of dementia.
ALCOHOL RELATED DEMENTIA
Pathogenesis
• Withdrawal-induced glutamate excitotoxicity
(Hoffman, 1995) or oxidative stress (Brust, 2010).
• Alter expression of numerous brain gene expression
networks
• Alcohol metabolite acetaldehyde binds to select
proteins, resulting in the formation of adducts. These
adducts led to brain damage (Nakamura et al., 2000).
• Neurotoxic glutamatergic excitation that leads to
hippocampal and neocortical neuronal loss.
ALCOHOL RELATED DEMENTIA
• AD may have symptoms that overlap with other
common neurodegenerative cognitive disorders(e.g)
• Contrast to the other dementia AD more typically
have a rather globally impaired neuropsychological
profile , with similar impairment in most or all
domains even in early disease stages.
• The evaluation :-Likewise other dementia
• Rx:- Partially reversible on cessation of drinking.
Gazdzinski et al. (2005)
MARCHIAFAVA BIGNAMI DISEASE
“red wine drinker’s encephalopathy,”
• Acute:- severe impairment of consciousness, seizures, and
muscle rigidity often result in death after several days.
• Chronic :-An interhemispheric disconnection syndrome,
such as limb apraxia, tactile agraphia, unilateral agraphia,
hemialexia, and dementia, can be seen and can last for
months to years (Kim et al., 2007).
• Corpus callosum demyelination is the hallmark of MBD
diseaseParticular involvement of the splenium.(Tozakidou et al., 2011)
• Rx:-Strongly associated with thiamine deficiency (and
recovery may therefore occur with early recognition and
repletion)
• Other clinical conditions such as ischemia, multiple
sclerosis, lupus, and posterior reversible encephalopathy
syndrome.
Sandwich sign
CEREBELLAR DEGENERATION
• CD with or without micronutrient deficiency
states , such as thiamine deficiency. Depends
on duration and severity of alcohol intake
(Nicolas et al., 2000)
• Typically occurs after 10 or more years of
alcohol abuse (Baker et al., 1999; Andersen,
2004).
• Thought to be the most common CNS
complication of alcoholism, affecting 10% to
25% of alcoholics.
CEREBELLAR DEGENERATION
• Most typically, the superior cerebellar vermis is
principally involved, with multilayer neuronal loss
(particularly affecting Purkinje cells) and cerebellar
white matter loss.
• The number of years of heavy alcohol abuse may be
the strongest single determinant of alcoholic ataxia
development.
• Treatment of this disorder , aside from thiamine and
other micronutrient repletion , is largely supportive
once developed.
• Cerebellar dysfunction may improves or stabilizes
with abstinence and improved nutrition (Diener et al., 1984).
CENTRAL PONTINE MYELINOLYSIS
• Possibility that alcoholics are predisposed to myelin
disorders by environmental insults such as
hyponatremia with CPM.
• CPM is C/b a loss of oligodendrocytes and myelin in the
central pons (Adams et al., 1959).
• EPM has also been described most often involving the
white matter of the cerebellum, lateral geniculate
body, putamen, thalamus, hippocampus, and cerebral
transition of white and gray matter (Martin, 2004).
• C/F confusion, impaired cognition, dysarthria,
dysphasia, gait instability, weakness or paralysis, and
generalized seizures (Hurley et al., 2011).
• Rx :-Correction of Na & Vitamin supplementation.
ALCOHOLIC NEUROPATHY
ACUTE ALCOHOLIC NEUROPATHY:-
• Rare cases have been reported of alcoholics with severe
acute or subacute neuropathy that mimics Guillain Barre´
syndrome.(causal but unproven)
• Biopsy and electrodiagnostic data show an axonal pattern
(not demyelinating) with normal CSF protein.
COMPRESSIVE NEUROPATHIES
• Susceptibility to compression is a feature of most axonal
neuropathies , and acute radial neuropathy , or Saturday
night palsy, in alcoholics is well reported.
• However , alcoholics with a generalized peripheral
neuropathy are prone to compression neuropathy at many
different sites , including ulnar neuropathy at the elbow ,
radial or axillary nerve injury in the axilla ( crutch-type
compression ) , and fibular ( peroneal) neuropathy at the
fibular head .
ALCOHOLIC NEUROPATHY
CHRONIC ALCOHOLIC NEUROPATHY:-
• Painful sensory neuropathy in association with alcoholism was
recognized in the late 1700s.
• However , the question of the cause due to ethanol as a
putative direct nerve toxin or due to nutritional deficiency or
both, was debated until recently.
• Malnutrition and vitamin deficiency are common in chronic
alcoholics , and thiamine has been the primary focus of
investigation.
• Clear association between reduction of thiamine levels or
transketolase activity and alcoholic peripheral neuropathy has
not been conclusively established.
CHRONIC ALCOHOLIC NEUROPATHY
• Peripheral distal sensorimotor neuropathy with distal
axonopathy that is a common finding in alcoholic
patients (90%).
• Distal weakness and atrophy are usually late findings
following sensory disturbance and are less profound ,
with weakness that may be limited to toe extensors.
• Differences in thiamine levels or enzyme activity
between alcoholics with and without neuropathy
have not been consistently identified , even though
alcoholic neuropathy patients often do have reduced
levels of various vitamins.
CHRONIC ALCOHOLIC NEUROPATHY:-
• Chronic well fed alcoholics without vitamin
deficiency - slowly progressive sensory loss
affecting small-fiber-mediated functions, but
not ataxia or weakness from neuropathy.
• Primary non-alcoholic thiamine deficiency-
subacute weakness and sensory ataxia from
large-diameter > small-diameter fiber sensory
neuropathy.
• Autonomic symptoms are not uncommon
ALCOHOLIC NEUROPATHY-Rx
• Cessation from ethanol is paramount to
improvement .
• Despite apparently adequate nutrition,
multivitamin supplements and thiamine are
indicated for all alcoholic neuropathy patients.
• Long-term follow-up of reformed alcoholics
demonstrates that significant improvement of
alcoholic neuropathy is possible, although often
incomplete.
• Patients with mild to moderate neuropathy can
significantly improve ,but the improvement is
usually incomplete in those with severe findings.
ALCOHOLIC MYOPATHY
ACUTE
• Develops over hours to days
following a recent binge.
• Painful, Proximal, may regional or
even focal, swollen muscles ,
variable weakness,
• Usually with myoglobinuria and
markedly elevated CK that
normalizes within 1 to 2 weeks.
• Muscle destruction –
Fasting/drinking
• Attacks can be recurrent,
correlating with additional
episodes of heavy drinking.
• Recovery following cessation of
drinking and repletion of
electrolytes is usually rapid and
dramatic.
CHRONIC
• Develops in an indolent manner
over many months. Roughly 2% of
all adults.
• Painless , proximal weakness with
wasting (up to 30%)
• Myoglobinuria is absent, and
creatine kinase(CK) is normal,
reduced, or mildly elevated, unless
an acute myopathy is
superimposed.
• Muscle Bx- atrophy of type II fibers,
which contain a higher content of
glycolytic enzymes.
• Prolonged abstinence can improve
clinical weakness and is associated
with significant improvement
TAKE HOME MESSAGE
• Alcoholism can produces a diverse spectrum
of neurologic disease when abused.
• Alcohol interacts acutely predominantly with
GABA-A and NMDA receptors, but triggers
diverse signaling events within well-defined
neural pathways.
• Early recognition and despite apparently
adequate nutritional deficiency one should
supplements thiamine and multivitamin for all
alcoholic patients.
THANK YOU

More Related Content

What's hot

PARKINSON’S DISEASE
PARKINSON’S DISEASEPARKINSON’S DISEASE
PARKINSON’S DISEASE
Dr. Kapil Dev Doddamani
 
multiple sclerosis- recent guidelines 2018
multiple sclerosis- recent guidelines 2018multiple sclerosis- recent guidelines 2018
multiple sclerosis- recent guidelines 2018
NeurologyKota
 
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptxMOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
Zubair Sarkar
 
Non motor manifestations of pd
Non motor manifestations of pdNon motor manifestations of pd
Non motor manifestations of pd
NeurologyKota
 
Approach to myelopathy
Approach to myelopathy  Approach to myelopathy
Approach to myelopathy
ikramdr01
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs
Hajra Matloob (RPH)
 
hashimoto encephalopathy
hashimoto encephalopathyhashimoto encephalopathy
hashimoto encephalopathy
abdullah alzahrani
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
NeurologyKota
 
Approach to dementia
Approach to dementiaApproach to dementia
Approach to dementiaSarath Menon
 
How to localize neurological lesion
How to localize neurological lesionHow to localize neurological lesion
How to localize neurological lesion
Beenish Iqbal
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
akifab93
 
Spinocerebellar ataxia
Spinocerebellar ataxiaSpinocerebellar ataxia
Spinocerebellar ataxia
Tanat Tabtieang
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
Priyanka Thakur
 
Motor Neuron Disease
Motor Neuron DiseaseMotor Neuron Disease
Motor Neuron Disease
NeurologyKota
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalusNeurologyKota
 
Approach to parkinsonism
Approach to parkinsonismApproach to parkinsonism
Approach to parkinsonism
NeurologyKota
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
Praveen Nagula
 
Newer antiepileptic drugs
Newer antiepileptic drugsNewer antiepileptic drugs
Newer antiepileptic drugs
NeurologyKota
 

What's hot (20)

Approach to Peripheral Neuropathy
Approach to Peripheral NeuropathyApproach to Peripheral Neuropathy
Approach to Peripheral Neuropathy
 
PARKINSON’S DISEASE
PARKINSON’S DISEASEPARKINSON’S DISEASE
PARKINSON’S DISEASE
 
multiple sclerosis- recent guidelines 2018
multiple sclerosis- recent guidelines 2018multiple sclerosis- recent guidelines 2018
multiple sclerosis- recent guidelines 2018
 
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptxMOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
MOTOR FLUCTUATIONS IN ADVANCED PARKINSON’S DISEASE.pptx
 
Non motor manifestations of pd
Non motor manifestations of pdNon motor manifestations of pd
Non motor manifestations of pd
 
Approach to myelopathy
Approach to myelopathy  Approach to myelopathy
Approach to myelopathy
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs
 
hashimoto encephalopathy
hashimoto encephalopathyhashimoto encephalopathy
hashimoto encephalopathy
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
 
Approach to dementia
Approach to dementiaApproach to dementia
Approach to dementia
 
How to localize neurological lesion
How to localize neurological lesionHow to localize neurological lesion
How to localize neurological lesion
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Spinocerebellar ataxia
Spinocerebellar ataxiaSpinocerebellar ataxia
Spinocerebellar ataxia
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
 
Motor Neuron Disease
Motor Neuron DiseaseMotor Neuron Disease
Motor Neuron Disease
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalus
 
Approach to parkinsonism
Approach to parkinsonismApproach to parkinsonism
Approach to parkinsonism
 
UKPDS overview
UKPDS overviewUKPDS overview
UKPDS overview
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Newer antiepileptic drugs
Newer antiepileptic drugsNewer antiepileptic drugs
Newer antiepileptic drugs
 

Viewers also liked

Ppt on alcohol in neurology
Ppt on alcohol in neurologyPpt on alcohol in neurology
Ppt on alcohol in neurology
Sachin Adukia
 
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
angela_arciniegas
 
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
Alex J Mitchell
 
Alcoholism and wernicke korsakoff syndrome treatment
Alcoholism and wernicke korsakoff syndrome treatmentAlcoholism and wernicke korsakoff syndrome treatment
Alcoholism and wernicke korsakoff syndrome treatmentkevinnsmiith
 
Wernicke Korsakoff
Wernicke KorsakoffWernicke Korsakoff
Wernicke Korsakoff
kattillac
 
Korsakoff’s syndrome (korsakoff’s psychosis)
Korsakoff’s syndrome (korsakoff’s psychosis)Korsakoff’s syndrome (korsakoff’s psychosis)
Korsakoff’s syndrome (korsakoff’s psychosis)
Nursing Path
 
Wernicke’s encephalopathy
Wernicke’s encephalopathyWernicke’s encephalopathy
Wernicke’s encephalopathy
Amiteshwar Singh
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior Change
Center on Addiction
 
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzyme
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzymeThiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzyme
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzymeautumnpianist
 
Wernicke –korsahoff syndrome
Wernicke –korsahoff syndromeWernicke –korsahoff syndrome
Wernicke –korsahoff syndrome
mohammedhazazi
 
Neurogenic Bladder
Neurogenic BladderNeurogenic Bladder
Neurogenic Bladder
Bharat Bhushan
 
Alcohol’S Effects On The Brain
Alcohol’S Effects On The BrainAlcohol’S Effects On The Brain
Alcohol’S Effects On The BrainHaerodien
 
Alcohol Presentation
Alcohol PresentationAlcohol Presentation
Alcohol Presentationktorgerson
 
TEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkTEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of Work
Volker Hirsch
 

Viewers also liked (17)

Ppt on alcohol in neurology
Ppt on alcohol in neurologyPpt on alcohol in neurology
Ppt on alcohol in neurology
 
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
 
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
LPT05 - Treatment of Wernicke-Korsakoff Syndrome (Aug 2005)
 
Alcoholism and wernicke korsakoff syndrome treatment
Alcoholism and wernicke korsakoff syndrome treatmentAlcoholism and wernicke korsakoff syndrome treatment
Alcoholism and wernicke korsakoff syndrome treatment
 
Wernicke Korsakoff
Wernicke KorsakoffWernicke Korsakoff
Wernicke Korsakoff
 
Korsakoff’s syndrome (korsakoff’s psychosis)
Korsakoff’s syndrome (korsakoff’s psychosis)Korsakoff’s syndrome (korsakoff’s psychosis)
Korsakoff’s syndrome (korsakoff’s psychosis)
 
Wernicke’s encephalopathy
Wernicke’s encephalopathyWernicke’s encephalopathy
Wernicke’s encephalopathy
 
Polyneuropathy
PolyneuropathyPolyneuropathy
Polyneuropathy
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior Change
 
Wernicke encephalopathy
Wernicke encephalopathyWernicke encephalopathy
Wernicke encephalopathy
 
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzyme
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzymeThiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzyme
Thiamine (vitamin b1) and riboflavin (vitamin b2) actions as co-enzyme
 
Wernicke –korsahoff syndrome
Wernicke –korsahoff syndromeWernicke –korsahoff syndrome
Wernicke –korsahoff syndrome
 
Neurogenic Bladder
Neurogenic BladderNeurogenic Bladder
Neurogenic Bladder
 
epidemiology.ppt22
epidemiology.ppt22epidemiology.ppt22
epidemiology.ppt22
 
Alcohol’S Effects On The Brain
Alcohol’S Effects On The BrainAlcohol’S Effects On The Brain
Alcohol’S Effects On The Brain
 
Alcohol Presentation
Alcohol PresentationAlcohol Presentation
Alcohol Presentation
 
TEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of WorkTEDx Manchester: AI & The Future of Work
TEDx Manchester: AI & The Future of Work
 

Similar to DR. BHARAT BHUSHAN (DM-NEUROLOGY) ASSOCIATE PROFESSOR GOVERNMENT MEDICAL COLLEGE,KOTA

Antiparkinson's drugs and antiepileptic drugs
Antiparkinson's drugs and antiepileptic drugsAntiparkinson's drugs and antiepileptic drugs
Antiparkinson's drugs and antiepileptic drugs
gayathiri Vinodh
 
Management of Epilepsy, GTCS,
 Management of Epilepsy, GTCS, Management of Epilepsy, GTCS,
Management of Epilepsy, GTCS,
ankitamishra1402
 
recent advances in antiepileptics
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepilepticspriyanka527
 
epilepsy-210211104538.pdf
epilepsy-210211104538.pdfepilepsy-210211104538.pdf
epilepsy-210211104538.pdf
Roop
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
HimikaRathi
 
Drugs &amp; toxins associated seizures in emergency departments
Drugs &amp; toxins associated seizures in emergency departments  Drugs &amp; toxins associated seizures in emergency departments
Drugs &amp; toxins associated seizures in emergency departments
Dr.Venugopalan Poovathum Parambil
 
Adverse effects of antipsychotic drugs
Adverse effects of antipsychotic drugsAdverse effects of antipsychotic drugs
Adverse effects of antipsychotic drugs
Domina Petric
 
Drugs for Affective Disorders
Drugs for Affective DisordersDrugs for Affective Disorders
Drugs for Affective Disorders
RAJESHWAR CHAVAN
 
status epilepticus in child je workshop mks
status epilepticus in child je workshop mksstatus epilepticus in child je workshop mks
status epilepticus in child je workshop mks
drmksped
 
NMS.pptx
NMS.pptxNMS.pptx
NMS.pptx
ShanuSoni7
 
anti-convulsants.ppt
anti-convulsants.pptanti-convulsants.ppt
anti-convulsants.ppt
waruirujane001
 
Dr. Surendra SGPGI
Dr. Surendra SGPGIDr. Surendra SGPGI
Dr. Surendra SGPGI
surendra kumar
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
NeurologyKota
 
Anti epileptic drugs
Anti epileptic drugs Anti epileptic drugs
Anti epileptic drugs
Shruti Shirke
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
NeurologyKota
 
Epilepsy and Recent Advances.pptx
Epilepsy and Recent Advances.pptxEpilepsy and Recent Advances.pptx
Epilepsy and Recent Advances.pptx
KarabiAdak
 
Parkinsonism final
Parkinsonism final Parkinsonism final
Parkinsonism final
Dr. Vijay Prasad
 
Pharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugsPharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugs
Arfi12
 
NMS Neuroleptic malignant syndrome
NMS Neuroleptic malignant syndromeNMS Neuroleptic malignant syndrome
NMS Neuroleptic malignant syndrome
alyaqdhan
 

Similar to DR. BHARAT BHUSHAN (DM-NEUROLOGY) ASSOCIATE PROFESSOR GOVERNMENT MEDICAL COLLEGE,KOTA (20)

Antiparkinson's drugs and antiepileptic drugs
Antiparkinson's drugs and antiepileptic drugsAntiparkinson's drugs and antiepileptic drugs
Antiparkinson's drugs and antiepileptic drugs
 
Seizure disorders
Seizure disordersSeizure disorders
Seizure disorders
 
Management of Epilepsy, GTCS,
 Management of Epilepsy, GTCS, Management of Epilepsy, GTCS,
Management of Epilepsy, GTCS,
 
recent advances in antiepileptics
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepileptics
 
epilepsy-210211104538.pdf
epilepsy-210211104538.pdfepilepsy-210211104538.pdf
epilepsy-210211104538.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Drugs &amp; toxins associated seizures in emergency departments
Drugs &amp; toxins associated seizures in emergency departments  Drugs &amp; toxins associated seizures in emergency departments
Drugs &amp; toxins associated seizures in emergency departments
 
Adverse effects of antipsychotic drugs
Adverse effects of antipsychotic drugsAdverse effects of antipsychotic drugs
Adverse effects of antipsychotic drugs
 
Drugs for Affective Disorders
Drugs for Affective DisordersDrugs for Affective Disorders
Drugs for Affective Disorders
 
status epilepticus in child je workshop mks
status epilepticus in child je workshop mksstatus epilepticus in child je workshop mks
status epilepticus in child je workshop mks
 
NMS.pptx
NMS.pptxNMS.pptx
NMS.pptx
 
anti-convulsants.ppt
anti-convulsants.pptanti-convulsants.ppt
anti-convulsants.ppt
 
Dr. Surendra SGPGI
Dr. Surendra SGPGIDr. Surendra SGPGI
Dr. Surendra SGPGI
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
 
Anti epileptic drugs
Anti epileptic drugs Anti epileptic drugs
Anti epileptic drugs
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
 
Epilepsy and Recent Advances.pptx
Epilepsy and Recent Advances.pptxEpilepsy and Recent Advances.pptx
Epilepsy and Recent Advances.pptx
 
Parkinsonism final
Parkinsonism final Parkinsonism final
Parkinsonism final
 
Pharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugsPharmacology of anti epileptic drugs
Pharmacology of anti epileptic drugs
 
NMS Neuroleptic malignant syndrome
NMS Neuroleptic malignant syndromeNMS Neuroleptic malignant syndrome
NMS Neuroleptic malignant syndrome
 

Recently uploaded

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

DR. BHARAT BHUSHAN (DM-NEUROLOGY) ASSOCIATE PROFESSOR GOVERNMENT MEDICAL COLLEGE,KOTA

  • 1. DR. BHARAT BHUSHAN (DM-NEUROLOGY) ASSOCIATE PROFESSOR GOVERNMENT MEDICAL COLLEGE,KOTA
  • 2.
  • 3. PHENOMENOLOGY • Alcoholic = Person (T1>25yr M/F, T2<25yr male only) • Alcoholism =Illness (abuse /dependence) • Physical Dependence :The development of withdrawal symptoms once a drug is stopped. • Binge Drinking: A “binge” is a pattern of drinking alcohol that brings BAC to 0.08 gm% or above. >5 drinks (male) or >4 drinks (female) in about 2 hours. • Craving:- The desire to experience the effects of a previously experienced psycho-active substance. • Tolerance:- represents a CNS pharmacodynamic adaptive response which improves neurologic function at a given blood alcohol level.
  • 4. METABOLISM • Role of alcoholism in the development of cognitive and functional decline has been known since the time of Hippocrates • Two-carbon molecule that rapidly diffuses into virtually every biologic compartment in the body upon ingestion. • Women have a lower alcohol dehydrogenase blood content than Men. Rate of oxidation is constant(15mg/dl/hr) does not depend on plasma level.
  • 6. ALCOHOL AND THE BRAIN TRANSCRIPTOME • Chronic exposure acts by many multiple myelin- related genes /ligand-gated ion channels / neuromodulatory molecules /Neuroinflammatory signaling genes are in both humans and animal models (Blednov et al., 2011, 2012). • Genetic predisposition - 50% of the vulnerability for developing alcohol dependence (Goodwin et al., 1974; Prescott and Kendler, 1999). • Polymorphisms in isoforms of ADH and ALD genes, which influence alcohol metabolism and the risk for alcoholism (Park et al., 2013).
  • 7. ALCOHOL AND THE BRAIN TRANSCRIPTOME
  • 8. SPECTRUM Acute Acute alcoholic intoxication Alcoholic blackout Alcohol withdrawal syndromes • Minor = Tremulousness, 6- 24 hr • Major = Hallucinosis 10-72 hours • Withdrawal seizures=Rum fit , within 6-48 hrs • Delirium tremens (DTs):-3-10 days Chronic Nutritional deficiencies: Wernicke-Korsakoff syndrome. Alcoholic polyneuropathy Pellagra Uncertain etiology • Alcoholic cerebellar degeneration. • Central pontine myelinolysis. • Marchiafava-Bignami disease • Alcoholic myopathy. • Alcoholic neuropathy
  • 9. ACUTE EFFECTS- INTOXICATION • Intoxication occurs –d/t readily crosses the BBB • Facilitation of GABA and Inhibition of Glutmate • Clinical intoxication is related to the rate of blood ethanol increase and the individual’s ethanol tolerance (d/t Zero order kinetics).
  • 10. INTOXICATION • EEG :- beta (fast) activity ----> slowing. • Reduces sleep onset latency , sleep efficiency , duration of REM sleep and with diminished perceived sleep quality. Rx:-Supportive. • Low dose BZD: Lorazepam PO/IV 1-2mg • Alternative: Antipsychotic Haloperidol or Olanzenpine. • Parenteral thiamine should also used
  • 11. ALCOHOL BLACKOUTS • Alcohol blackouts occur in the absence of any loss of consciousness or seizure activity and represent a type of anterograde amnesia. • Fragmentary or en bloc alcohol blackouts . • Perhaps by interfering with septohippocampal regulation of hippocampal neuronal circuitry (Givens et al., 2000).
  • 12. ALCOHOL WITHDRAWAL SYNDROME Withdrawal A physiological state, d/t cessation/reduction in amount of drug ,Generally opposite of drug’s normal effects. Spectrum AWS • Minor withdrawal= Tremulousness, 6-24 hrs • Major withdrawal= Hallucinosis 10-72 hours • Withdrawal seizures=Rum fit ,within 6-48 hrs • Delirium tremens (DTs):-3-10 days
  • 13. ALCOHOLIC HALLUCINOSIS Alcoholic hallucinosis: – Occurs in about 2% of patients – Characterized by presence of hallucinations [usually auditory] during partial or complete abstinence, following regular alcohol intake. Treatment: – Lorazepam oral 3-10 mg every 4-6 hr – Correction of electrolyte disorders: hypokalemia and hypomagnesemia, hyperthermia,
  • 14. ALCOHOLIC SEIZURE (RUM FITS) – GTCS & multiple seizures occur in about 10% of alcohol dependence patients, usually 12 to 48 hrs after abstinence. – Sometimes status epileptics can be precipitated (less than 3%) – Unless an underlying neuropathology exists, seizures are rarely focal. – Seizures sometimes occur during heavy drinking or after more than a week without alcohol – Arrhythmias and sudden cardiac death can occur. – EEG are mildly abnormal and usually revert to normal within few days
  • 15. EFNS- RECOMMENDATION(2011) Treatment: BDZ: Diazepam: IV 0.5 mg/kg at 2.5 mg/ min No WS/Mild to Moderate symptoms no routine seizure prevention(Level B ). Severe alcohol withdrawal symptoms, regardless of seizure occurrence, should be treated pharmacologically (Level C recommendation). Status epilepticus: i.v. lorazepam is safe and efficacious. When unavailable, i.v. diazepam is a good alternative (Level A recommendation). Primary Preventions BZD for primary prevention of seizures in a person with alcohol withdrawal, as well as for treatment of the alcohol withdrawal syndrome. Other drugs for detoxification should only be considered as add -on (Level A). Secondary prevention BZD should be used for the secondary prevention of AWS (Level A). Phenytoin is not recommended for prevention of AWS recurrence (Level A recommendation). The efficacy of other antiepileptics for secondary prevention of AWS is undocumented.
  • 16. DELIRIUM TREMENS Occurs within 3 to 4 days Features of:- - Clouding of consciousness with disorientation in time and place with tremulousness of body - Poor attention span and distractibility - Visual hallucinations and illusions - Marked autonomic disturbances - Insomnia - Dehydration with electrolyte imbalance Treatment: 50-100 mg Chlordiazepoxide every 4 hrs orally or Lorazepam IV 0.1 mg/kg at 2 mg/min.  Prevention: 25-50 mg of Chlordiazepoxide every 2-4 hrs until out of danger.  High calorie, high carbohydrate diet given with Thiamine suppliment.
  • 17. CHRONIC COMPLICATIONS Alcoholic Pellagra • Disease of cerebral function attributed to deficiency of nicotinic acid or tryptophan (Serdaru et al 1988; Victor 1994). • Rare now because of widespread practice of niacin supplementation of cereals and bread • Initial symptoms are mood changes and neurasthenia.May progress to lethargy and confusion, variably accompanied by spastic paresis, paratonia, or myoclonus.
  • 18. Wernicke-Korsakoff Syndrome German neurologist and psychiatrist, born May 15, 1848, Tarnowskie Gory, Poland; died June 15, 1905, Russian neuropsychiatrist, born January 22, 1853, Gus estate, Vladimirsk; died May 1, Moscow, 1900. Karl Wernicke(1848-1905)
  • 19. WERNICKE ENCEPHALOPATHY • WE is an acute, potentially reversible, neuropsychiatric disorder caused by thiamine deficiency (Donnino et al., 2007; Isenberg-Grzeda et al., 2012). • The incidence can be as high as 12.5% • The altered cognition of WE can progress to KS, a chronic and usually permanent.(Toth et al., 2002). • Approximately 80% of patients with acute WE will develop KS (Donnino et al., 2007). • Mechanism:- Chronic alcoholism– Malnutrition – reduced thiamine uptake and utilization
  • 20. PHYSICAL EXAMINATION • The diagnosis of Wernicke syndrome is often suspected based on clinical grounds. • Theclassicaltriadofsymptoms–only1/3rd ofcases • Ocularabnormalities–nystagmus,bilaterallateral rectuspalsies,conjugategazepalsies,sluggishpupils, ptosis,andanisocoria • Encephalopathy– globalconfusionalstate,disinterest, inattentiveness,or agitation;Comaisrare. • Gaitataxia– cerebellardamage,andvestibularparesis • Peripheralneuropathy– foot drop,anddecreased proprioception 20
  • 21. Figure 1. [A and B] FLAIR images depicting hyperintensities in the periaqueductal region [A] and medial thalamus [B]. Pre- [C] and Post- [D] contrast T1-weighted images showing contrast enhancement of the mammillary bodies. Wernicke-Korsakoff Syndrome
  • 22. Differential Diagnosis • Psychosis • Normal pressure hydrocephalus • Cerebrovascularaccident • Chronic hypoxia • Closed-head injury • Hepatic encephalopathy • Postictal state
  • 23. WORK-UP • Erythrocyte transketolase activity assay, Thiamine assay – very specific tests – not widely available – reserved for diagnostic dilemmas • EEG and CSF analysis may exclude other explanatory or concomitant conditions.
  • 24. TREATMENT • Emergencydepartmentcare–Parenteralthiamine–Requirementin chronicalcoholicsmaybeas highas500mgsingledoseormultipledaily doses. • NeverstartonDextrose • Treatment with thiamine repletion, currently recommended at 1 gram of IV thiamine per 24 hours for alcoholics with suspected Wernicke encephalopathy , should not be delayed. • Death occurs in nearly 20 % of patients with delayed treatment. • Parenteralmagnesiumsulfateasthiaminetherapyineffectivein presenceofhypomagnesemia. • In-Patientcare–Watchforcomplications–Korsakoffpsychosis–Alcohol withdrawal–Congestiveheartfailure–Lacticacidosis • Out-PatientCare–Thiamine100mgPOdaily,startalcoholcessation program,Adviseonimportanceofbalanceddiet. 24
  • 25. KORSAKOFF SYNDROME:- • Another CNS syndrome resulting from thiamine deficiency in alcoholics. • It manifests with Psychosis, memory loss and confabulation, abulia. • Korsakoff syndrome is distinguished from acute Wernicke syndrome by prominent anterograde and retrograde amnesia without substantially impaired alertness and attention or extraocular movement disturbance. • 85% of the survivors of the acute phase of Wernicke encephalopathy who remain untreated go on to develop Wernicke-Korsakoffsyndrome. • 20% eventuallyrecovercompletelyduring long-termF/U care.
  • 26. KORSAKOFF SYNDROME • Epidemiologicallly cases of undiagnosed Wernicke syndrome can progress to Korsakoff syndrome. • Patients may have a significant degree of vacuous spontaneous speech and abulia that may be mistaken for depressive symptoms when inadequately explored. • Thalamus (particularly the anterior thalamic nucleus) and hypothalamus (medial mammillary nucleus) are injured , but other cortical and subcortical areas modulate this process.
  • 27. PROGNOSIS OF WKS • 10-20% mortality rate (in acute stages) • In general, full recovery of ocular function occurs. Fine horizontal nystagmus can persist in - 60% of cases. • Approximately 40% of patients have complete recovery from ataxia. • Of patients surviving WE 80% have Korsakoff psychosis. • KS 25% do not recover, require long-term admission. • Only about 20% eventually recover completely during long-term follow-up care. • Only 20% of patients recover completely from amnestic deficit. • Despite appropriate treatment ,measureable memory deficiency may persist for upto 2 years in patients with Wernicke encephalopathy.
  • 28. ALCOHOL RELATED DEMENTIA • Represent approximately 10% of all cases of dementia (Gupta and Warner, 2008). • With advancing age , patients who are chronic alcoholics may develop cognitive impairment or dementia without demonstrable micronutrient deficiency. • Synergistic in the expression of other cognitive disorders of aging. • Clinically, patients with alcohol related dementia typically present at an earlier age than other acquired or late-onset forms of dementia.
  • 29. ALCOHOL RELATED DEMENTIA Pathogenesis • Withdrawal-induced glutamate excitotoxicity (Hoffman, 1995) or oxidative stress (Brust, 2010). • Alter expression of numerous brain gene expression networks • Alcohol metabolite acetaldehyde binds to select proteins, resulting in the formation of adducts. These adducts led to brain damage (Nakamura et al., 2000). • Neurotoxic glutamatergic excitation that leads to hippocampal and neocortical neuronal loss.
  • 30. ALCOHOL RELATED DEMENTIA • AD may have symptoms that overlap with other common neurodegenerative cognitive disorders(e.g) • Contrast to the other dementia AD more typically have a rather globally impaired neuropsychological profile , with similar impairment in most or all domains even in early disease stages. • The evaluation :-Likewise other dementia • Rx:- Partially reversible on cessation of drinking. Gazdzinski et al. (2005)
  • 31. MARCHIAFAVA BIGNAMI DISEASE “red wine drinker’s encephalopathy,” • Acute:- severe impairment of consciousness, seizures, and muscle rigidity often result in death after several days. • Chronic :-An interhemispheric disconnection syndrome, such as limb apraxia, tactile agraphia, unilateral agraphia, hemialexia, and dementia, can be seen and can last for months to years (Kim et al., 2007). • Corpus callosum demyelination is the hallmark of MBD diseaseParticular involvement of the splenium.(Tozakidou et al., 2011) • Rx:-Strongly associated with thiamine deficiency (and recovery may therefore occur with early recognition and repletion) • Other clinical conditions such as ischemia, multiple sclerosis, lupus, and posterior reversible encephalopathy syndrome.
  • 33. CEREBELLAR DEGENERATION • CD with or without micronutrient deficiency states , such as thiamine deficiency. Depends on duration and severity of alcohol intake (Nicolas et al., 2000) • Typically occurs after 10 or more years of alcohol abuse (Baker et al., 1999; Andersen, 2004). • Thought to be the most common CNS complication of alcoholism, affecting 10% to 25% of alcoholics.
  • 34. CEREBELLAR DEGENERATION • Most typically, the superior cerebellar vermis is principally involved, with multilayer neuronal loss (particularly affecting Purkinje cells) and cerebellar white matter loss. • The number of years of heavy alcohol abuse may be the strongest single determinant of alcoholic ataxia development. • Treatment of this disorder , aside from thiamine and other micronutrient repletion , is largely supportive once developed. • Cerebellar dysfunction may improves or stabilizes with abstinence and improved nutrition (Diener et al., 1984).
  • 35. CENTRAL PONTINE MYELINOLYSIS • Possibility that alcoholics are predisposed to myelin disorders by environmental insults such as hyponatremia with CPM. • CPM is C/b a loss of oligodendrocytes and myelin in the central pons (Adams et al., 1959). • EPM has also been described most often involving the white matter of the cerebellum, lateral geniculate body, putamen, thalamus, hippocampus, and cerebral transition of white and gray matter (Martin, 2004). • C/F confusion, impaired cognition, dysarthria, dysphasia, gait instability, weakness or paralysis, and generalized seizures (Hurley et al., 2011). • Rx :-Correction of Na & Vitamin supplementation.
  • 36. ALCOHOLIC NEUROPATHY ACUTE ALCOHOLIC NEUROPATHY:- • Rare cases have been reported of alcoholics with severe acute or subacute neuropathy that mimics Guillain Barre´ syndrome.(causal but unproven) • Biopsy and electrodiagnostic data show an axonal pattern (not demyelinating) with normal CSF protein. COMPRESSIVE NEUROPATHIES • Susceptibility to compression is a feature of most axonal neuropathies , and acute radial neuropathy , or Saturday night palsy, in alcoholics is well reported. • However , alcoholics with a generalized peripheral neuropathy are prone to compression neuropathy at many different sites , including ulnar neuropathy at the elbow , radial or axillary nerve injury in the axilla ( crutch-type compression ) , and fibular ( peroneal) neuropathy at the fibular head .
  • 37. ALCOHOLIC NEUROPATHY CHRONIC ALCOHOLIC NEUROPATHY:- • Painful sensory neuropathy in association with alcoholism was recognized in the late 1700s. • However , the question of the cause due to ethanol as a putative direct nerve toxin or due to nutritional deficiency or both, was debated until recently. • Malnutrition and vitamin deficiency are common in chronic alcoholics , and thiamine has been the primary focus of investigation. • Clear association between reduction of thiamine levels or transketolase activity and alcoholic peripheral neuropathy has not been conclusively established.
  • 38. CHRONIC ALCOHOLIC NEUROPATHY • Peripheral distal sensorimotor neuropathy with distal axonopathy that is a common finding in alcoholic patients (90%). • Distal weakness and atrophy are usually late findings following sensory disturbance and are less profound , with weakness that may be limited to toe extensors. • Differences in thiamine levels or enzyme activity between alcoholics with and without neuropathy have not been consistently identified , even though alcoholic neuropathy patients often do have reduced levels of various vitamins.
  • 39. CHRONIC ALCOHOLIC NEUROPATHY:- • Chronic well fed alcoholics without vitamin deficiency - slowly progressive sensory loss affecting small-fiber-mediated functions, but not ataxia or weakness from neuropathy. • Primary non-alcoholic thiamine deficiency- subacute weakness and sensory ataxia from large-diameter > small-diameter fiber sensory neuropathy. • Autonomic symptoms are not uncommon
  • 40. ALCOHOLIC NEUROPATHY-Rx • Cessation from ethanol is paramount to improvement . • Despite apparently adequate nutrition, multivitamin supplements and thiamine are indicated for all alcoholic neuropathy patients. • Long-term follow-up of reformed alcoholics demonstrates that significant improvement of alcoholic neuropathy is possible, although often incomplete. • Patients with mild to moderate neuropathy can significantly improve ,but the improvement is usually incomplete in those with severe findings.
  • 41. ALCOHOLIC MYOPATHY ACUTE • Develops over hours to days following a recent binge. • Painful, Proximal, may regional or even focal, swollen muscles , variable weakness, • Usually with myoglobinuria and markedly elevated CK that normalizes within 1 to 2 weeks. • Muscle destruction – Fasting/drinking • Attacks can be recurrent, correlating with additional episodes of heavy drinking. • Recovery following cessation of drinking and repletion of electrolytes is usually rapid and dramatic. CHRONIC • Develops in an indolent manner over many months. Roughly 2% of all adults. • Painless , proximal weakness with wasting (up to 30%) • Myoglobinuria is absent, and creatine kinase(CK) is normal, reduced, or mildly elevated, unless an acute myopathy is superimposed. • Muscle Bx- atrophy of type II fibers, which contain a higher content of glycolytic enzymes. • Prolonged abstinence can improve clinical weakness and is associated with significant improvement
  • 42. TAKE HOME MESSAGE • Alcoholism can produces a diverse spectrum of neurologic disease when abused. • Alcohol interacts acutely predominantly with GABA-A and NMDA receptors, but triggers diverse signaling events within well-defined neural pathways. • Early recognition and despite apparently adequate nutritional deficiency one should supplements thiamine and multivitamin for all alcoholic patients.

Editor's Notes

  1. This is the senerio where we stand inside and outside the country with alcohol burden. This map was polated by Nimhan study
  2. Alcoholics are obsessed with alcohol and cannot control how much they consume, even if it is causing serious problems at home, work, and financially , also known as alcohol usedisorder (AUD) and alcohol dependence syndrome, is a broad term for any drinking ofalcohol that results in problems. It was previously divided into two types: alcoholabuse and alcohol dependence.
  3. This drug is almost ubiquitous, widely enjoyed socially, but produces a diverse spectrum of neurologic disease when abused This fact may account for women’s tendency to become more intoxicated than men after drinking the same amount of alcohol.
  4. There has been robust demonstration that acute or chronic alcohol exposure can alter expression of the genome The explosion of genomic information about alcohol and the brain that has been produced since the turn of the century is almost bewildering in magnitude and scope (Contet, 2012; Farris and Miles, 2012). mu-opioid receptor gene show promise as a pharmacogenetic risk factor altering responses to naltrexone, a mu-opioid receptor antagonist t- treatment of alcoholism (Ray and Hutchison, 2007; Ramchandani et al., 2011).
  5. Hypothetic scheme for the role of myelin in alcoholism and alcohol-related neurologic disorders. Basal myelin expression is pictured as affecting initial sensitivity to alcohol, such as with loss-of-righting reflex (LORR), and perhaps relatedly, alcohol consumption. Acute alcohol, however, also alters myelin gene expression, which may contribute to frontal-lobe dysfunction and the consequent development of abusive alcohol consumption. Chronic alcohol exposure produces prominent decreases in myelin gene expression and myelin structural abnormalities. These are envisioned as contributing to frontal-lobe dysfunction in alcoholism and alcoholic dementia. Additionally, alcohol-induced myelin pathology may contribute as a risk factor to other alcohol-related neurologic diseases, such as Wernicke–Korsakoff’s syndrome (WKS), Machiafava–Bignami disease (MBD), central pontine myelinolysis (CPM), and cerebellar degeneration (CD).
  6. Minor withdrawal Minor withdrawal (withdrawal tremulousness) occurs within 6-24 hours following the patient’s last drink and is characterized by tremor, anxiety, nausea, vomiting, and insomnia. Major withdrawal (alcoholic hallucinosis) Major withdrawal (hallucinations) occurs 10-72 hours after the last drink. The signs and symptoms include visual and auditory hallucinations, whole body tremor, vomiting, diaphoresis, and hypertension. Withdrawal seizures Withdrawal seizures (rum fits) occur within 6-48 hours of alcohol cessation; they are major motor seizures that take place during withdrawal in patients who normally have no seizures and have normal electroencephalograms (EEGs). These seizures are typically generalized and brief. In the absence of treatment, multiple seizures occur in 60% of patients, but the duration between the first and last seizure is usually less than 6 hours. Only 3% of patients go on to develop status epilepticus. An alcohol withdrawal seizure is frequently the first sign of alcohol withdrawal, and no other signs of withdrawal may be present after the seizure abates. About 30-40% of patients with alcohol withdrawal seizures progress to DTs. Alcohol withdrawal seizures usually occur only once or recur only once or twice, and they generally resolve spontaneously. If a patient has seizures that are not typical of alcohol withdrawal seizures (such as partial or focal seizures, prolonged seizures, or seizures with a prolonged postictal state) or has signs of significant head trauma, then the underlying cause of the seizure should be investigated. Alcohol-dependent patients have increased rates of idiopathic epilepsy, traumatic brain injury, stroke, and intracranial mass lesions. Moreover, seizures in alcohol-dependent patients may be caused by concomitant use of stimulant drugs, such as cocaine or amphetamines, or by withdrawal from sedative agents, such as benzodiazepines or barbiturates. Delirium tremens DTs is the most severe manifestation of alcohol withdrawal. It occurs 3-10 days following the last drink. Clinical manifestations include agitation, global confusion, disorientation, hallucinations, fever, hypertension, diaphoresis, and autonomic hyperactivity (tachycardia and hypertension). Profound global confusion is the hallmark of delirium tremens.
  7. Withdrawal seizures do not represent "latent" epilepsy; therefore, treatment with anticonvulsants is not recommended
  8. Additionally, KS has additional causes other than WE, including primary CNS lymphoma (Toth et al., 2002) and mammillothalamic tract infarction (Yoneoka et al., 2004).
  9. Ocular motor signs are attributable to lesions in the brainstem affecting the abducens nuclei and eye movement centers in the pons and midbrain. Ataxia is a manifestation of damage to the cerebellum, particularly the superior vermis and also the vestibular apparatus
  10. Idea is to exclude alternate or coexisting medical conditions.
  11. In one study by Gazdzinski et al. (2005), Abstinent for 1 month and the tissue volume continued to increase over the next 6–9 months of abstinence, but at a slower rate than the first month following initial abstinence.
  12. Sandwich sign
  13. Ethanol does appear to directly interfere with retrograde axonal transport in some animal models. Differences in thiamine levels or enzyme activity between alcoholics with and without neuropathy have not been consistently identified , even though alcoholic neuropathy patients often do have reduced levels of various vitamins. Chronic well fed alcoholics without vitamin deficiency primarily develop slowly progressive sensory loss affecting small-fiber-mediated functions, especially nociception ;pain and burning paresthesia are common in this group ,but not ataxia or weakness from neuropathy. Primary non-alcoholic thiamine deficiency associated neuropathy , in contrast, more typically produces prominent subacute weakness and sensory ataxia from large-diameter more than small-diameter fiber sensory neuropathy. Patients with both alcohol exposure and thiamine deficiency demonstrate a mixture of findings that lead to similar treatment paradigms addressing both states. Typically begin with distal paresthesia in the feet and slowly progress proximally. In most cases , the onset is typically slow and insidious and may begin to affect the hands once leg symptoms ascend well above ankle level, thus yielding the classic symmetric stocking-glove sensory pattern. Ankle deep tendon reflexes are typically lost at a relatively early stage.